BODI underwent a dramatic operational turnaround with substantially reduced losses despite significant revenue decline, coupled with meaningfully improved cash position and debt reduction.
The company achieved a remarkable improvement in profitability, transforming from massive losses to near break-even while simultaneously strengthening its balance sheet with nearly doubled cash reserves. However, the substantial revenue decline of 40% indicates either significant operational restructuring or market challenges that investors must carefully evaluate against the improved financial efficiency.
BODI's financial picture reflects a dramatic restructuring story - while revenue declined substantially by 40% to $252M, the company achieved remarkable operational efficiency by nearly eliminating losses (improving from -$72M to -$3M). The balance sheet strengthened considerably with cash nearly doubling to $39M, total liabilities falling 21% to $116M, and inventory reduced by 42%, suggesting improved working capital management and debt reduction efforts that position the company on more stable financial footing despite the revenue challenges.
Net income grew 96% — bottom-line growth signals improving overall business health.
Cash position surged 93.3% — strong cash generation or capital raise providing significant financial cushion.
Inventory drawn down 42.3% — strong sell-through or deliberate destocking; watch for supply constraints.
Revenue declined 39.9% — significant demand weakness or market share loss warrants investigation.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Current liabilities reduced — improved short-term financial position and working capital health.
Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.
Receivables declined — improved collection efficiency or conservative revenue recognition.
Liabilities reduced 21% — deleveraging improves balance sheet strength and financial flexibility.
Current assets declined 18.9% — monitor working capital adequacy and short-term liquidity.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →